Reuters logo
BRIEF-Xenon Pharmaceuticals reports Q3 loss per share $0.43
November 7, 2017 / 10:08 PM / a month ago

BRIEF-Xenon Pharmaceuticals reports Q3 loss per share $0.43

Nov 7 (Reuters) - Xenon Pharmaceuticals Inc

* Xenon Pharmaceuticals reports third quarter 2017 financial results and provides corporate update

* Q3 revenue $300,000 versus $400,000

* Xenon Pharmaceuticals Inc - qtrly loss per share $0.43 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below